Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) shares were unchanged Thursday. The Wexford, Pa.-based biopharmaceutical company developing innovative cell therapy platforms for cancer, announced that it has completed the exclusive license of key .
Coeptics Flat On Deverra Deal menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
Form 424B4 Coeptis Therapeutics streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Coeptis Therapeutics (COEP) to Acquire Allogeneic Immuno-Oncology NK Platform in Phase 1 Clinical Trials from Deverra Therapeutics streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.